Product Information

MEPROBAMATE 200 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $4.5179 per EA under NDC 62332001931. Its NADAC has been published 168 times since May 11, 2016.

FDA first approved this application on Feb 18, 2009. Its Orange Book therapeutic-equivalence code is AA.

MEPROBAMATE 200 MG TABLET

Meprobamate
$4.5179per EA
DEA Schedule CIV

Strength

200 mg/1

NDC

62332001931

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

MEPROBAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090122

FDA Approved

2/18/2009

TE Code

AA

On Market Since

3/31/2016

Price Statistics

The NADAC for MEPROBAMATE 200 MG TABLET has been published 168 times since May 11, 2016, and over the history we have for it it has risen 215.7%. The table below summarizes its recorded NADAC range and movement.

Current price$4.5179 per EA
All-time high$5.0893 (Mar 11, 2026)
All-time low$1.4312 (May 11, 2016)
52-week high$5.0893
52-week low$3.9537
Median price$3.9537
Average price$3.4096
Largest weekly change+236.1% (Jul 17, 2024)
Weeks tracked168
Tracking sinceMay 11, 2016

Price History

1W

-1.0%

1M

-1.0%

3M

-5.8%

6M

-11.2%

1Y

+14.3%

3Y

+203.1%

5Y

+203.1%

All

+215.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of MEPROBAMATE 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MEPROBAMATE 200 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $4.5179 per EA (NDC 62332001931), effective Aug 19, 2026.

How has the price of MEPROBAMATE 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for MEPROBAMATE 200 MG TABLET has risen 215.7%. It has been tracked across 168 weekly CMS publications since May 11, 2016.

What are the highest and lowest recorded NADAC prices for MEPROBAMATE 200 MG TABLET?

Since May 11, 2016, the NADAC for MEPROBAMATE 200 MG TABLET has ranged from a low of $1.4312 (May 11, 2016) to a high of $5.0893 (Mar 11, 2026), with a median of $3.9537 per EA.

Are there cheaper alternatives to MEPROBAMATE 200 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MEPROBAMATE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MEPROBAMATE 200 MG TABLET?

MEPROBAMATE 200 MG TABLET (NDC 62332001931) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.